Treatment guidelines for Hepatitis C in Spain
| Autor: | M Crespo-Casal |
|---|---|
| Rok vydání: | 2015 |
| Předmět: |
Oral
medicine.medical_specialty Efficacy Genotype Hepatitis C virus Consensus Development Conferences as Topic efficacy lcsh:Medicine Administration Oral Hepacivirus medicine.disease_cause prisons administration Antiviral Agents Hepatic Diseases Drug Administration Schedule oral medicine Humans Limited evidence hepatitis c Intensive care medicine Strategic planning Government business.industry lcsh:Public aspects of medicine lcsh:R lcsh:RA1-1270 General Medicine Hepatitis C Hepatitis C Chronic medicine.disease Start up United States Europe Spain Prisons Administration Practice Guidelines as Topic Hcv treatment Drug Therapy Combination business |
| Zdroj: | Revista Española de Sanidad Penitenciaria v.17 n.2 2015 SciELO España. Revistas Científicas Españolas de Ciencias de la Salud instname Revista Española de Sanidad Penitenciaria, Vol 17, Iss 2, Pp 37-47 |
| ISSN: | 2013-6463 |
| Popis: | The discovery of new orally administered drugs that can block different targets of the replication cycle of the hepatitis C virus (HCV) with major antiviral activity, has revolutionized treatment of this infection and relegated interferon-based treatments to a secondary position. The start up of the National Strategic Plan for Combating Hepatitis C, which acknowledges the greater efficacy and safety of oral antiviral drugs, as well as the agreements between the pharmaceutical companies and different government bodies has enabled the initial difficulties of access to these medicines due to their high cost to be overcome. In this rapidly changing environment, the availability of a therapeutic guide based on a critical analysis of the available evidence, takes on special relevance and provides a basic support for medical practitioners involved in HCV treatment. However, the speed with which new therapeutic options are included and the limited evidence in some clinical scenarios signifies a challenge for those responsible for scientific societies whose job it is to coordinate the preparation of therapeutic guides and to keep recommendations up to date. In this review we analyze the treatment recommendations for HCV in a consensus document drawn up by the Spanish Association for the Study of Liver Diseases (AEEH), to contrast them with recommendations given by American and European associations that study hepatic diseases. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|